Cue Biopharma, Inc. — Director's Dealing 2025

Jan 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2025-01-02

Reporting Person: Garzone Pamela (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-02	Stock Option (right to buy)	$1.09	A	24400	Acquired	2035-01-01	Common Stock (24400)	Direct

Footnotes

F1: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.

F2: This option was granted on January 2, 2025. The option is scheduled to vest as to 50% of the underlying shares on the six-month anniversary of the grant date and as to the remaining 50% on the first anniversary of the grant date.